Minerva Neurosciences, Inc. (NERV)
NASDAQ: NERV · IEX Real-Time Price · USD
2.580
+0.060 (2.38%)
At close: Mar 28, 2024, 4:00 PM
2.530
-0.050 (-1.94%)
After-hours: Mar 28, 2024, 5:20 PM EDT
Minerva Neurosciences Market Cap
Minerva Neurosciences has a market cap or net worth of $17.76 million as of March 28, 2024. Its market cap has increased by 97.37% in one year.
Market Cap
17.76M
Enterprise Value
-23.25M
1-Year Change
97.37%
Ranking
Category
Stock Price
$2.58
Market Cap Chart
Since July 1, 2014, Minerva Neurosciences's market cap has decreased from $110.60M to $17.76M, a decrease of -83.94%. That is a compound annual growth rate of -17.11%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Mar 27, 2024 | 17.50M | -2.78% |
Mar 26, 2024 | 18.00M | -3.23% |
Mar 25, 2024 | 18.60M | -0.53% |
Mar 22, 2024 | 18.70M | 3.31% |
Mar 21, 2024 | 18.10M | -4.23% |
Mar 20, 2024 | 18.90M | 2.16% |
Mar 19, 2024 | 18.50M | -2.12% |
Mar 18, 2024 | 18.90M | -3.08% |
Mar 15, 2024 | 19.50M | 1.56% |
Mar 14, 2024 | 19.20M | -2.54% |
Mar 13, 2024 | 19.70M | 1.55% |
Mar 12, 2024 | 19.40M | -1.52% |
Mar 11, 2024 | 19.70M | 0.51% |
Mar 8, 2024 | 19.60M | 9.50% |
Mar 7, 2024 | 17.90M | -1.65% |
Mar 6, 2024 | 18.20M | - |
Mar 5, 2024 | 18.20M | 1.11% |
Mar 4, 2024 | 18.00M | -2.17% |
Mar 1, 2024 | 18.40M | -1.60% |
Feb 29, 2024 | 18.70M | -5.56% |
Feb 28, 2024 | 19.80M | 1.02% |
Feb 27, 2024 | 19.60M | -58.82% |
Feb 26, 2024 | 47.60M | -0.83% |
Feb 23, 2024 | 48.00M | -5.33% |
Feb 22, 2024 | 50.70M | -17.56% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Senti Biosciences | 19.55M |
Xilio Therapeutics | 19.48M |
Gyre Therapeutics | 19.42M |
NeurAxis | 18.99M |
CareCloud | 18.70M |
Context Therapeutics | 18.60M |
Onconova Therapeutics | 18.23M |
Centogene | 18.11M |